BRIEF-Glaxosmithkline says ViiV Healthcare starts Phase 3 HIV prevention study in women
November 30, 2017 at 02:41 AM EST
* VIIV HEALTHCARE, CO OWNED BY GSK, WITH PFIZER INC. AND SHIONOGI LTD AS SHAREHOLDERS, TO START PHASE III STUDY FOR PREVENTION OF HIV INFECTION IN SEXUALLY ACTIVE WOMEN Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)
